ICYMI: Two federal courts separately denied requests from plaintiffs who wanted to force FDA to...
FTC won’t probe PBMs
After an afternoon of hearing from various stakeholders, the Federal Trade Commission decided (by a 2-2 vote) not to begin a probe of PBMs and whether and how they violate anti-trust laws.
Just three PBMs control nearly 80% of the market, and they are now affiliated with health insurers, their own pharmacies, doctor's offices and other health-care entities to create [...] both horizontal and vertical monopolies.
The good news: The commission members who voted not to probe the agency said they aren’t against it, they just needed a more comprehensive, data-centric proposal first.
